LEXINGTON, Mass., Feb. 6, 2012 (GLOBE NEWSWIRE) -- Curis, Inc. (Nasdaq:CRIS), a drug development company seeking to develop proprietary targeted medicines for cancer treatment, today announced that the Company will be presenting at the 14th Annual BIO CEO & Investor Conference at 10:00 a.m. EST on February 13, 2012, in New York City.
